|
|
|
|
|
Tuesday, April 14, 2009
|
|
|
12:55 pm -
2:40 pm
|
- Broad level definition of personalized medicine from a provider perspective
- Specific Mayo Clinic initiatives to leverage personalized medicine advances and Mayo Clinic's use of pharmacogenomics to differentiate individuals from populations
- The Center for Innovation's business model and delivery methods for personalized medicine
- Opportunities and challenges of reimbursement, physician adoption, comparative effectiveness and others
|
|
|
Nicholas F. LaRusso, MD
Charles H. Weinman Endowed Professor of Medicine and Director of the Center for Innovation
Mayo Clinic
 View Biography
|
- Definition of personalized medicine from a diagnostics perspective, the role of accurate diagnosis and how it will evolve
- Innovative diagnostics companies and future impact on the diagnostics market
- Challenges of the current diagnostic reimbursement system
- Successes in oncology diagnostics and specifically comparing blood cancers vs. solid tumors
|
|
Mara G. Aspinall
former President, Genzyme Genetics;
Visiting Lecturer, Dana-Farber Cancer Institute/Harvard Medical School
View Biography
|
- Direct to Consumer genetic information--why now?
- How 23andMe provides a platform for translational studies and helps build the case for evidence-based personalized medicine.
- Challenges of the consumer market: IP, regulation and acceptance by the research and medical fields.
|
|
|
Linda Avey
Co-Founder
23andMe
View Biography
|
- How payers define and interpret personalized medicine
- Successes in diagnostics to improve the quality and cost of care
- System dysfunctions to drive value for personalized medicine
- Payer challenges: Comparative effectiveness, ensuring the validity of tests, measuring value and managing costs
|
|
Joanne Armstrong, MD, MPH
Senior Medical Director
Aetna
View Biography
|
| Moderator: |
|
Douglas J. Moeller, MD
Medical Director, Claims Performance
McKesson
View Biography
|
|
|
3:10 pm -
4:50 pm
|
- Implications for standards and progress toward interoperability
- Next steps for the national health information infrastructure
|
|
John W. Loonsk, MD
Chief Medical Officer, CGI Federal
Former Director, Office of Interoperability and Standards
Office of the National Coordinator for Health Information Technology
Department of Health and Human Services
View Biography
|
- Private sector perspective on pending legislation and initiatives
- Update on certification of health IT
|
|
|
Mark Leavitt, MD, PhD
Chairman
Certification Commission for Healthcare Information Technology
View Biography
|
|
|
Simon P. Cohn, MD, MPH
Associate Executive Director, The Permanente Federation, Kaiser Permanente;
Former Chair, National Committee on Vital and Health Statistics;
Member, Board of the American Health Information Community (AHIC)
View Biography
|
- A leading payer's perspective on the opportunities for interoperable health care including how the payer community needs to adapt
- Views on the extent to which interoperability needs to be driven from the private vs. the public sector e.g. regulation, incentives, compliance, etc.
|
|
Reed V. Tuckson, MD, FACP
Executive Vice President and Chief of Medical Affairs
UnitedHealth Group
View Biography
|
| Moderator: |
|
Charles Jaffe, MD, PhD, FACMI
Chief Executive Officer
Health Level 7, Inc.
View Biography
|
|
| Additional Thought Leaders TBA |
|
|
|
10:40 am -
12:20 pm
|
|
Frank Rijsberman
Project Director, Predict and Prevent
Google.org
View Biography
|
- The Aravind Eye Hospital business model — Generating a 52 percent profit margin from paying patients to maintain the programs and to provide services to other low-income patients
- An innovative and bold strategy to make medical technologies available to poorer populations through the creation of a nonprofit manufacturing company that produces medical device and other medical supplies
- Results of the extremely affordable innovations, including implanted intraocular lenses (IOLs) to restore sight for cataract patients for $2 to $10 each (typically $100-$150), ophthalmic sutures at $25/box (vs. market rate of $200/box) and hearing aids
|
- The Healthstore mission to provide essential medications and inexpensive generics to battle the infectious diseases that treat 70- 90% of all childhood illness and death
- The business model and franchise approach – Applying microenterprise principles with proven franchise business practices to create a micro-franchise business model called CFWshops™
- Operational strategies of the CFWshops -- Franchisees enable trained health workers to operate their own businesses by operating small drug shops or clinics with the support of the HealthStore drug handling and distribution regulations to ensure good practice
- Results to date from the 82 CFWshops in operation in Kenya and future plans for expansion
|
|
|
Scott D. Hillstrom, JD
Founder, Chairman and President
The HealthStore Foundation
View Biography
|
|
Tricia Morente
Market and Strategy
LifeSpring Hospitals
|
|
| Additional Thought Leaders TBA |
|
|
|
|
|
|
Printer Friendly
Email A Colleague
Bookmark Page